Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a Metropolitan Detroit health system

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 5, 2010, Pages 2235-2238

  Reddy, Tara ^a   Chopra, Teena ^a   Marchaim, Dror ^a   Pogue, Jason M ^b   Alangaden, George ^a   Salimnia, Hossein ^c   Boikov, Dina ^c   Navon Venezia, Shiri ^d   Akins, Robert ^c   Selman, Philip ^c   Dhar, Sorabh ^a   Kaye, Keith S ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c DETROIT MEDICAL CENTER   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM; BETA LACTAMASE INHIBITOR; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; MEROPENEM; MINOCYCLINE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TIGECYCLINE; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; GENOTYPE; HEALTH SERVICE; INCIDENCE; INFECTION CONTROL; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TREND STUDY;

ACADEMIC MEDICAL CENTERS; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AMPICILLIN; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; IMIPENEM; MICHIGAN; PHYLOGENY; PREVALENCE; RETROSPECTIVE STUDIES; SULBACTAM; URBAN POPULATION;

EID: 77951226065     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01665-09     Document Type: Article

References (28)

1. Abbo, A., Y. Carmeli, S. Navon-Venezia, Y. Siegman-Igra, and M. J. Schwaber. 2007. Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes. Eur. J. Clin. Microbiol. Infect. Dis. 26:793-800.
2. Abbo, A., S. Navon-Venezia, O. Hammer-Muntz, T. Krichali, Y. Siegman-Igra, and Y. Carmeli. 2005. Multidrug-resistant Acinetobacter baumannii. Emerg. Infect. Dis. 11:22-29.
3. Bassetti, M., E. Righi, S. Esposito, N. Petrosillo, and L. Nicolini. 2008. Drug treatment for multidrug-resistant Acinetobacter baumannii infections. Future Microbiol. 3:649-660.
4. Bou, G., G. Cervero, M. A. Dominguez, C. Quereda, and J. Martinez-Beltran. 2000. PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii. Clin. Microbiol. Infect. 6:635-643.
5. Casal, M., F. Rodriguez, B. Johnson, E. Garduno, F. Tubau, R. O. de Lejarazu, A. Tenorio, M. J. Gimenez, R. Bartolome, C. Garcia-Rey, L. Aguilar, and N. Garcia-Escribano. 2009. Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp. J. Antimicrob. Chemother. 64:69-72.
6. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. Approved standard M100-S16. CLSI, Wayne, PA.
7. European Committee on Antimicrobial Susceptibility Testing Steering Committee. 2006. EUCAST technical note on tigecycline. Clin. Microbiol. Infect. 12:1147-1149.
8. Falagas, M. E., and S. K. Kasiakou. 2005. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. 40:1333-1341.
9. Giske, C. G., D. L. Monnet, O. Cars, and Y. Carmeli. 2008. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob. Agents Chemother. 52:813-821.
10. Gounden, R., C. Bamford, R. van Zyl-Smit, K. Cohen, and G. Maartens. 2009. Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections. BMC Infect. Dis. 9:26.
11. Hidron, A. I., J. R. Edwards, J. Patel, T. C. Horan, D. M. Sievert, D. A. Pollock, and S. K. Fridkin. 2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29:996-1011.
12. Jain, R., and L. H. Danziger. 2004. Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians. Ann. Pharmacother. 38:1449-1459.
13. Karlowsky, J. A., D. C. Draghi, M. E. Jones, C. Thornsberry, I. R. Friedland, and D. F. Sahm. 2003. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob. Agents Chemother. 47:1681-1688.
14. Landman, D., S. Bratu, S. Kochar, M. Panwar, M. Trehan, M. Doymaz, and J. Quale. 2007. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY. J. Antimicrob. Chemother. 60:78-82.
15. Leung, W. S., C. M. Chu, K. Y. Tsang, F. H. Lo, K. F. Lo, and P. L. Ho. 2006. Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest 129:102-109.
16. Levin, A. S. 2003. Treatment of Acinetobacter spp. infections. Expert Opin. Pharmacother. 4:1289-1296.
17. Maragakis, L. L., and T. M. Perl. 2008. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin. Infect. Dis. 46:1254-1263.
18. Marchaim, D., S. Navon-Venezia, A. Leavitt, I. Chmelnitsky, M. J. Schwaber, and Y. Carmeli. 2007. Molecular and epidemiologic study of polyclonal outbreaks of multidrug-resistant Acinetobacter baumannii infection in an Israeli hospital. Infect. Control Hosp. Epidemiol. 28:945-950.
19. Paul, M., M. Weinberger, Y. Siegman-Igra, T. Lazarovitch, I. Ostfeld, I. Boldur, Z. Samra, H. Shula, Y. Carmeli, B. Rubinovitch, and S. Pitlik. 2005. Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997-2002. J. Hosp. Infect. 60:256-260.
20. Peleg, A. Y., H. Seifert, and D. L. Paterson. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582.
21. Petrosillo, N., P. Chinello, M. F. Proietti, L. Cecchini, M. Masala, C. Franchi, M. Venditti, S. Esposito, and E. Nicastri. 2005. Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events. Clin. Microbiol. Infect. 11:682-683.
22. Pillar, C. M., D. C. Draghi, M. J. Dowzicky, and D. F. Sahm. 2008. In vitro activity of tigecycline against gram-positive and gram-negative pathogens as evaluated by broth microdilution and Etest. J. Clin. Microbiol. 46:2862-2867.
23. Rosenthal, V. D., D. G. Maki, A. Mehta, C. Alvarez-Moreno, H. Leblebicioglu, F. Higuera, L. E. Cuellar, N. Madani, Z. Mitrev, L. Duenas, J. A. Navoa-Ng, H. G. Garcell, L. Raka, R. F. Hidalgo, E. A. Medeiros, S. S. Kanj, S. Abubakar, P. Nercelles, and R. D. Pratesi. 2008. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. Am. J. Infect. Control 36:627-637.
24. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
25. Versalovic, J., T. Koeuth, and J. R. Lupski. 1991. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 19:6823-6831.
26. Vila, J., M. A. Marcos, and M. T. Jimenez de Anta. 1996. A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex. J. Med. Microbiol. 44:482-489.
27. Wilson, S. J., C. J. Knipe, M. J. Zieger, K. M. Gabehart, J. E. Goodman, H. M. Volk, and R. Sood. 2004. Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital. Am. J. Infect. Control 32:342-344.
28. Young, L. S., A. L. Sabel, and C. S. Price. 2007. Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit. Infect. Control Hosp. Epidemiol. 28:1247-1254.